A Botanical Strategy for Advanced and Hormone-Resistant Prostate Cancer

Introduction to Sylvie Beljanski 0:00

Welcome everyone to the Prostate Cancer Summit 2.0. And it's my pleasure to introduce to you, Sylvie Beljanski, who is who does so many things we were just discussing. So, Sylvie Beljanski is the CEO of black Beljanski Products nutraceuticals, which I think many of you would know about if you have been, diagnosed or affected by prostate cancer. By now. She's also the, host for the Beljanski Cancer Talk Show podcast. She runs the Integrative Cancer Conference and is the author of The Magnificent book Winning the War on Cancer.

Sylvie, such a pleasure to see you. Well, thank you. Thank you for having me today. So we, you know, we go back, you and I, I was I wouldn't say that I had here when we first met, but I would say that my beard was black when we said, absolutely. That's something like 20, almost 20 years ago. Yeah. That's right. When we did some research at Columbia University, I was with Doctor Irene Kass at the time. Yes. And we did some research on prostate about one of the products that we're going to talk about, which was, you know, fascinating is actually, it was one of my first real gigs, right?

It was my first research project that I was so proud of. I remember recruiting patients for it and, you know, looking into, you know, Paul and Ralphie, and, and doing some deep research with some of your scientists and discussing it with you guys. It was so much fun. And I do remember that part of that story. Probably most of that story came from the research that your father did, back in France.

Mirko Beljanski's Cancer Research Origins 1:56

If I remember his name. Mirko. Belgian. Is that right? Yes, Commissioner. Ski. Indeed. Yes. He was a PhD in molecular biology, was working at the Pasteur Institute, which is more or less a French equivalent for NIH. And, he was one of the first scientists at the time to look at the environment as a cruise and as a solution to, to cancer back in the 70s and 80s. So everybody was thinking that, you know, genetics would be the solution to everything. A lot of money was pouring into genetic understanding and discovering genetic drugs that will modify the genome.

So genome was just something new and exciting. Gets a dime. Just discovered by Watson and Crick. And my father said, well, if it's if it's on, cancer is only genetic. There would not be an increase of cancer. It would be pretty stable. The fact that it is increasing is showing us that there is something probably in our environment which is triggering that something at the level of our DNA. And makes us that tells us the cells to, to become cancers. And, he developed a test, that, allowed him to, to discover a number of molecules in our environment that, induce cancer.

He made actually, the difference between the, made the observations that there is a fundamental difference between the DNA of healthy cells, the DNA of cancer cells, the DNA of healthy cells are nicely, the DNA is nicely interwoven. And what nicely kept together with the hydrogen bonds. And when a cell turns cancerous. And whether you look at plants, animals, humans, the the the DNA is a double helix is not well kept together. The hydrogen bonds are broken. So he had the idea to, measure the amount of light going through the two strands of the DNA.

And he made a correlation that the more light, going through the strands of the DNA, the faster the DNA duplicates. So he had a way to test for numbers of molecules and see if they were increasing the rate of synthesis of DNA. And then you looked for for molecules that would recognize selectively these, destabilized DNA, prevent the duplication selectively off of those cells and, and have no effect on healthy cells. And it's beautiful. When you look under the microscope, you can see that release of plant extracts, which happened to be naturally fluorescent.

You see them really targeting cancer cells. And then it's really striking, especially under UV light. And, and they don't go anywhere, inside healthy cells. They stay like a halo of your essence outside of healthy cells. It's it's absolutely beautiful. But that translated into, plant extracts that we cognize cancer cells wherever they are located and, have no toxicity, no, no side effects for an unhealthy cells. So it became pretty, pretty successful with that. Back in the, in the 80s, had, a big following of, of French, doctors who were using, those products with a lot of success and different kinds of cancer.

And then, and then in the 90s, former French President Francois Mitterrand was diagnosed with advanced prostate cancer. So the official, surgeon came to the French White House, said, the cancer has spread everywhere else. The president is probably not going to be able to finish his second term tempts with seven years. So it's a time in France and, we are going to give him some of seen and, try to keep him comfortable, but we have to prepare the country for early elections. But the mistress and the mistress knew about a good doctor who had good results on prostate cancer by using my first products.

So Mitterrand started to take the products and, again, sold out the stock to to get better. So that did not sit well with the pharmaceutical company. So we are furious that it was I mean, there was no social media and things like that. That took time, but it was the president. So it was really visible to all that. He was looking very, very bad. And then this started to to get better and attend conferences and things like that and ask you as a scientist who has decided that, I mean, pharmaceutical companies

Mitterrand Case and Foundation Legacy 7:10

and, and, the political class was, was absolutely infuriated. So exactly nine months after Mitterrand finally passed away, after having finished his second term. The sense yammy the French government sends the army to destroying Max forces, a laboratory. They came with with, machine, against dogs and helicopters circling above the, laboratories. And I said, my my father, my mom, the doctors who were working with them, pharmacist who was, overseeing the, the production, everything. And it was it tried to to destroy everything.

And I'm sorry to hear that. And, did you're and are we talking about the products or ingredients that we are still working with today? So this is your pal and your role? Yeah, absolutely. Absolutely. It's the same products, that, Mitterrand, was taking. When I saw what was happening, I said, over my dead body, I'm not going to let that knowledge, disappear. And that's why I decided here in the States to start the British Foundation. My goal was to continue to make the products available and, to confirm my father's research, to show that, indeed, those little plant extracts were recognizing cancer cells are no toxicities, unhealthy cells and, were, actually pretty effective.

And that's a that's a classic, a work of the foundation for the past 25 years. Unbelievable. On a personal note, your dad passed away in 1998, correct? Correct. Yes, yes. You think? And I don't know the details of them. We don't have to get into it. But do you think that distress or the disappointment of what happened, after all the work and research you did, you think that had an effect on his passing at all, or was it just aging? Oh no no no no no. First, that they did not follow the due process.

When you are somebody in France, you're supposed to bring in immediately before the judge. They told him, well, it's too late. We'll bring you tomorrow. Stay safe. And it came. So there was a team as a matter who came and, send some gas. Where? In the laboratory. And two months later, he was diagnosed with, acute myeloid leukemia, at 74. I tried to send him products as quickly as I could manufacture. Ehm, but, I mean, there was no way I could save him. I was able to maintain him alive for two years, and, that gave him the time also to pass to me a lot of knowledge, a lot of information, and to test the the plant extracts that I was sending give, from, from America.

And at some point in September 98th, he told me, well, you know how to do it. Don't, just don't change anything, and you will be fine. And, the following months, he passed. And at what point? So when did you start working with your dad? And in the products I got. I was a lawyer by trade. I was working in the New York Law firm. I did not like it. Oh, so you guys ready new York? Just working as a lawyer. Nothing to do with the company? No, the problem exactly. I'm the product of, several generations of scientists, and, I grew up like a little brat saying, I don't want to get involved in health with.

I don't want to be surrounded with sick people. I don't talk about changing well, in one's life. Yes, exactly. But, I knew how, how much you were helping people. I grew up seeing people coming at home. They were crying, and,

Sylvie's Path Into the Family Work 11:16

And that because they had been diagnosed with cancer, and then they were coming back seven months later with flowers, chocolate. Growing up beautiful. I mean, I was a little brat. It felt like, this is a never ending. I don't want those people in my life. But, I knew how important this work was. And, and, as an adult, I felt, I felt the responsibility to, to make sure that the barbarians would not win and that the knowledge would not disappear. So let's thank you for sharing that, by the way. That's, very touching.

Just on a personal level, it was very touching. So now we have these products that I remember, you know, studying at Columbia. We have, these, particularly the Bell, which contains, Russell is a roll we have on materia I we met him. Yes. It's a freezer pain free. That's really important. Three zapping, three, rubber extract. It's rich and stunning and stunning is very similar, to Flavor Brain, which is also, this is, active ingredients of popiah. So it's flavor purine and and stunning and, both, I've, shown the ability to induce apoptosis of a number of cancer cell lines, including prostate and within prostate.

We have, tested the product in vitro and in vivo on, and, hyperplasia, benign hyperplasia of prostate. We know that we have and modulation of NF Kappab. We know that, we have inhibition of five stars. We know that we have upregulation of p53. We know that we have apoptosis, of cancer cells. So it was, several mechanism of action which are cumulative, always going in in a good way. And that, helping at every stage, actually, of the cancer. So let's talk about some of the research that you've conducted around that.

We can start from the most recent and go as far back as you want, because one of the interesting things, and one of the reasons why I think that I admire your work is that, you know, you put your money where your mouth is, like they say in the US, right? You conducted the research. There are a lot of supplement companies who talk about what their supplements do, but there's no research behind it. Your, your you and your products are different. So tell us about some of the research on any stage of prostate cancer as it relates to Popper.

And Rufio. Yes. So, indeed. I mean, that's how we met because the mentions key Foundation was of was, conduit funding some research that was conducted at Columbia University, and, at Columbia University. Doctor Katz, told me, well, we are going to, to we can look at those, plant extracts, but, only one. So you have to choose. And I was like, but I know that those felt better. And for me telling you, I was working, so it's a heartbreaking issue you are lacking asking me to choose my between two of my kids, two of my children?

Prostate Cancer Research on Beljanski Products 14:32

That's right. And, I came up with the idea of combining them both and make one mix that we called, plus double for the purpose of the study, but. But we tested, in vitro and in vivo at Columbia University. The first it was on cancer cells, prostate cancer cells. And, we come up with some, really good publications that were signed and by the team of, of Columbia University, we had this little, clinical trial that, did not come to publication because some people, where, had to have a biopsy at the beginning, a biopsy at the end.

At the end. They did not want to have another biopsy. Different felt fine. That's right. It's it just went fine. So actually, it was they did not we are not able to publish, but we have a data showing that the PSA was improved, with all those patients. And, then we kept, in touch as, you left Colombia, but we stayed in touch with some, another PhD, student was still working at Colombia, and we were able to, to work on, concepts, advanced cancer cells that do not respond to, to hormonal treatment anymore.

PC, PC three I believe, cancer cell lines, which are pretty, pretty aggressive. Yeah. And we, we were able to see that, palpate and also covered over material independently were able to to, to inhibit the course of those very aggressive cancer cells. That's very important because, hormonal treatment at first is difficult to for men. It's, it's, I mean, castration of testosterone is something, difficult. And, sometimes at some point, it's, we know that testosterone schillings are cancer, but is not the cause of the cancer.

So that means at some points that so the treatment can fail and, and then down, not so many options that are given to, to those men. And what we saw is that the power behind revolution, for me to continue to be active, to be efficient against those very, aggressive, cells that have, escaped to, to power para and the revolution from Italy and to to hormonal treatment with what we have been able to see, is, the, synergy of action with the attack cell. We have done studies, on synergy of action with different chemotherapies.

My, my father at the time was already studying, documenting that with, cyclophosphamide, five, a few. And, here in the States we have done does it excel and we the work at Kansas University Medical Center. We have done the synergy on GMC with gemcitabine and carboplatin. So what we see is that those, those those, chemotherapies are very different kinds of molecules as a, different mechanism of action. But every time we have a nice synergy, with those, with those, plant extracts and do it seems that the toxicity, linked to, chemotherapies is actually participating to the destabilization of the DNA and make that for the cancer cells even more visible, recognizable for those little plant extracts.

We will invade the DNA of those, of the groups that my father described, I was describing. So there is good synergy between Paul and Ralphie. And, many of the chemotherapeutic drugs, it sounds like is for everything, not just for prostate cancer or advanced prostate cancer. Sounds like for any advanced prostate cancer. Any advanced cancer. Yes, sir. Research done that concept. University was on Orion and pancreatic cancer and also were extremely successful. And then we said since we are those plant extracts are doing so much at different stages of cancer, why not looking at cancer stem cells and cancer stem cells, nobody tend to speak about it because chemotherapies are enabled to destroy them.

But it's very important to address them from day one of the diagnosis, because they are thought to be responsible for metastasis. So we had the first, research done at Kansas University Medical Center on Ovarian and Pancreatic Cancer stem cells. And everything disappeared. Everything disappeared. So, we did a big, research, and we just finish. It's not published yet. And by the way, all the research I mentioned so far, everything is available on the website of the Belgian Ski Foundation, Belgian that, you can look at also survey, research, download, share with your doctor, see if it would be a good fit for you.

If we a website Sylvie Belgian ski.org or rg.org. So Belgian ski dawg okay we'll make sure to link it up as well. Yeah. So, we, we had this research that we just finished on breast cancer stem cells. So we had two groups, of, of mice. All of them were, received. This was very nasty, aggressive, human, breast. Cancer stem cells. And, you could see that, the control group had, a lot of big, very quickly big tumors and, and then to died pretty quickly.

Advanced Cancer and Stem Cell Studies 20:38

But, mice who, received so nasty cells that also were said and I think it is important to say fed because it was given us enough about five. Yeah. And some, some specific green tea or kitty. Let's say they had much less, tumors. So tumors were much smaller and there was zero metastasis. Zero. Wow. So, so the idea now that, we have done breast is what we are trying to find right now is prostate cancer stem cells. We believe we are going to see the same thing. But of course we have to do some research.

Amazing, amazing. If. Should we assume so you know prostate about which is the product that contains both Paul and Olivia. It's available for people to purchase. So. Should we assume that there is, stem cell benefits from taking profit about you? Obviously, you're doing the research first, which is amazing. But like we said before, there are a lot of people, a lot of companies promoting that their products do this and the other, they never study it. So I think it's okay for at least to have an assumption that based on your research, you already have, if there's benefit or not, I would say based on the positive results obtained on the ovarian pancreatic and breast cancer stem cells, I would assume is that there is nothing to lose to take it for, for prostate.

And even if, of course, even if they are an android deprivation therapy, in other words, doesn't matter what stage, particularly the more advanced stages, which that's when the situation becomes a little bit more critical for the patient. No negative interaction with docetaxel. And if the patient is on docetaxel, no negative interaction. And if they're in home hormone deprivation therapy and could possibly be beneficial in those circumstances, apparently, absolutely. And it was kind of hard emotionally to go from the prostate of the French president to in vitro studies and in mice, again, that could impact diversity.

But, but, you know, that was the way to go. And the only way to, to to make sure that this research would, would continue and that who would have scientific contribution validation that that was a now I, I want the listener to appreciate what goes into the research and what goes into formulating a research, because, I don't think that most people understand. There is funding that occurs, mostly from, your foundation. There is, looking at the right, stem, the right cells, in a petri dish, looking at, you know, having the right if you do an A in vivo study in other words, it's a process and you have to be very patient to get the results, then patient to publish those results 2 to 3 years.

You know, tens of thousands of dollars that they put up. So that's a that's admirable. Hundreds of thousands. Yeah. Hundreds of thousands. Yes. Right. Hundreds of thousands. Yeah. And that's why I mean that in order to fund the, the research, I have started to organize events and conferences and trying to create a one that's about about this research. I believe that beyond what we are doing, gets it from the foundation having I mean, integrative medicine will be taken seriously if everybody is doing good research.

I think quality research, sharing the research is a key for to credibility. And, and so beyond beyond this, I think it is really important for, for integrative medicine. And you, I mean, an integrative doctor, you are a natural athletic doctor. You have been to those. I mean, you have your degree in naturopathic medicine and, I think is having a quality body of people and of, of research is a way to, to, to justify going outside of, conventional medicine, which we have seen as its limits. Yeah, for sure.

And, you know, with the research, it becomes very slowly more accepted in mainstream medicine. It's a slow process. And like, like you said, look, no harm at a lot and potentially significant benefit from doing, you know, profitable, with advanced, advanced prostate cancer or advanced cancer, according to the research that you've performed. So lastly, any issues with the oncologist taking profitable.

Patient Use, Oncologist Discussions, and Testing 25:48

So typically they say don't do any supplements, just do this. How does the patient, how can the patient approach their oncologist to say, look, I'm also taking profit about I don't know. Here's the research. You can read up on it. What's the process like. Yeah. So that's making the research available because, I mean, a lot of doctors don't always I mean, there are a lot of things published every month. And doctors, I mean, it's difficult for them to keep up with what we say. But I think especially, I mean, natural stuff because they don't have cells. Right.

Bringing that to thing. So it's it's a source publications to them. So, it is a patient I mean, making publications easy to obtain to the patient. And if you go to the Belgian website, you can see my organ. It's organized by, by organ. So you can print everything related to prostate. Then you can start a discussion with your doctor and say and say, well, the mechanism of action. I explained service, apparently no toxicity. So why do you say no? And, very often you will discover that the doctor is kind of, as in the whole, doing some kind of study.

And, he doesn't want to mess up with, with the stats. But the question is, do you want to be a stat or do you have want to have a good result and taking good care of yourself and taking ownership? As a of what that answer really is? Sylvie, I think that sometimes. And look, I'm not a mainstream medicine basher. I work in mainstream medicine, but I think in some instances and in some institutions and in some oncologists, I do think is about the stats sometimes, sometimes. And I and I'm, and I'm hoping that that changes sooner than later.

Yeah. There are some, test also out there for one of them is rg, cc that allow people to send some, some blood and see, if against a panel of drugs and natural products, what, will be effective to, your specific cancer cells and, I have to say that, there's a plant extracts phobia. Robert Mitchell. Yes, appear in the panel as well, which is the name, used for the, professional line. But again and again, it's showing up as effective against a different kind of cancer. And, of course, prostate cancer.

Yes. Our, our, our GCC is, a CTC source, cancer tumor cells that they find on the and the blood and sometimes it's a company that, is able to match the right natural ingredients to that type of cancer. Yeah. Yeah. So, yeah, it's interesting that none do just natural, but they include chemotherapeutic drugs and things. Yeah. And on cabal, which is being uncovered if you have a media and golden gingko, which is also another, plant extract that my father, discovered, and we showed that it was beneficial to, helps, fight, skin, fibrosis, which can be interesting gifts to, to radiation.

And we did some further research with these golden gingko to show, that it was hemi beating arginine. So also, preventing the tumor to, to be fed with those, creation of new blood vessels and also to spread, by inhibiting arginine, which is the enzyme that helps cancer cells to create new blood vessels. So angiogenesis. Yeah. Very. Yeah. So, so, so we we have this combination of powerful gingko called on cabal and the Spartans, a professional line.

Where to Find Beljanski Resources 29:38

Now, uncle Bill needs to be prescribed by a physician. Yes, yes. That's, that's. Yes. Profitable. Sold direct to consumer. Absolutely. Great. Absolutely. Sylvie, thank you so much. Final words. And where can people find more about you? And perhaps that's Beljanski.org. Can you spell that for us as well just to make it? Yes. Beljanski. My last name is B e l j a n s k i. So Beljanski, Beljanski.org for the Beljanski Foundation and medicine. Beljanski medicine means home in French. And it's, m a i s o n, and and and my last name.com, for all the products and, and to find us in person here in New York and, and, you, you will also find, the maison Beljanski, all the information about our upcoming events as a conference.

And, and it is a podcast. Yeah, maybe I'm going to not say it with the beautiful French accent that you have, because I just don't have it. So it's maisonbeljanski.com. Come. Yes. M a i s o n beljanski.com. Correct. Sylvie, thank you so much. I appreciate you, your knowledge and your efforts and your hard work to make integrative medicine. In cancer, a real thing. So thank you. Thank you so much. Dr. G, thank you, thank you, everyone for watching the Prostate Cancer Summit interview with Sylvie Beljanski, the one and only.

Stay tuned. There's more to come. And we have interviews with really the best of the best in their respective fields as it relates to prostate cancer. Much love. I'll see you next time.